Loading…
Lobbying Spend
—
Filings
10
Firms Hired
1
Active Period
2016–2018
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
National Defense Authorization Act for Fiscal Year 2017
2016 · fourth_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 (PL 114-328) Comprehensive Addiction and Recovery Act of 2016 - Title VII, Section 746 Department of Defense Study on preventing the diversion of opiod medications S. 2943/H.R. 4909 (PL 114-198) National Defense Authorization Act for fiscal year 2017 - Title III, Section 301 Evidence based prescription opiod and heroin treatment and interventions demonstration
Client expense: — · Firm income: $10,000
Matched citations: H.R. 4909
Comprehensive Addiction and Recovery Act of 2015
2016 · fourth_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 (PL 114-328) Comprehensive Addiction and Recovery Act of 2016 - Title VII, Section 746 Department of Defense Study on preventing the diversion of opiod medications S. 2943/H.R. 4909 (PL 114-198) National Defense Authorization Act for fiscal year 2017 - Title III, Section 301 Evidence based prescription opiod and heroin treatment and interventions demonstration
Client expense: — · Firm income: $10,000
Matched citations: H.R. 953
National Defense Authorization Act for Fiscal Year 2017
2016 · fourth_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 (PL 114-328) Comprehensive Addiction and Recovery Act of 2016 - Title VII, Section 746 Department of Defense Study on preventing the diversion of opiod medications S. 2943/H.R. 4909 (PL 114-198) National Defense Authorization Act for fiscal year 2017 - Title III, Section 301 Evidence based prescription opiod and heroin treatment and interventions demonstration
Client expense: — · Firm income: $10,000
Matched citations: S. 2943
Comprehensive Addiction and Recovery Act of 2016
2016 · fourth_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 (PL 114-328) Comprehensive Addiction and Recovery Act of 2016 - Title VII, Section 746 Department of Defense Study on preventing the diversion of opiod medications S. 2943/H.R. 4909 (PL 114-198) National Defense Authorization Act for fiscal year 2017 - Title III, Section 301 Evidence based prescription opiod and heroin treatment and interventions demonstration
Client expense: — · Firm income: $10,000
Matched citations: S. 524
National Defense Authorization Act for Fiscal Year 2017
2016 · third_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act of 2016 S. 2943/H.R. 4909 - National Defense Authorization Act for fiscal year 2017
Client expense: — · Firm income: $10,000
Matched citations: H.R. 4909
Comprehensive Addiction and Recovery Act of 2015
2016 · third_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act of 2016 S. 2943/H.R. 4909 - National Defense Authorization Act for fiscal year 2017
Client expense: — · Firm income: $10,000
Matched citations: H.R. 953
National Defense Authorization Act for Fiscal Year 2017
2016 · third_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act of 2016 S. 2943/H.R. 4909 - National Defense Authorization Act for fiscal year 2017
Client expense: — · Firm income: $10,000
Matched citations: S. 2943
Comprehensive Addiction and Recovery Act of 2016
2016 · third_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act of 2016 S. 2943/H.R. 4909 - National Defense Authorization Act for fiscal year 2017
Client expense: — · Firm income: $10,000
Matched citations: S. 524
National Defense Authorization Act for Fiscal Year 2017
2016 · second_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act of 2016 S. 2943/H.R. 4909 - National Defense Authorization Act for fiscal year 2017
Client expense: — · Firm income: $10,000
Matched citations: H.R. 4909
Comprehensive Addiction and Recovery Act of 2015
2016 · second_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act of 2016 S. 2943/H.R. 4909 - National Defense Authorization Act for fiscal year 2017
Client expense: — · Firm income: $10,000
Matched citations: H.R. 953
National Defense Authorization Act for Fiscal Year 2017
2016 · second_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act of 2016 S. 2943/H.R. 4909 - National Defense Authorization Act for fiscal year 2017
Client expense: — · Firm income: $10,000
Matched citations: S. 2943
Comprehensive Addiction and Recovery Act of 2016
2016 · second_quarter · Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Issues relating to DEA's authority to regulate dispensing Schedule II-IV drugs S. 524/H.R. 953 - Comprehensive Addiction and Recovery Act of 2016 S. 2943/H.R. 4909 - National Defense Authorization Act for fiscal year 2017
Client expense: — · Firm income: $10,000
Matched citations: S. 524
Source: Senate LDA